W. P. Carey Inc. (WPC)
| Market Cap | 16.92B +25.9% |
| Revenue (ttm) | 1.74B +9.2% |
| Net Income | 516.84M +20.9% |
| EPS | 2.34 +20.6% |
| Shares Out | 222.74M |
| PE Ratio | 32.43 |
| Forward PE | 27.45 |
| Dividend | $3.72 (4.90%) |
| Ex-Dividend Date | Mar 31, 2026 |
| Volume | 682,396 |
| Open | 75.96 |
| Previous Close | 75.49 |
| Day's Range | 75.74 - 76.63 |
| 52-Week Range | 61.09 - 76.63 |
| Beta | 0.78 |
| Analysts | Hold |
| Price Target | 78.00 (+2.7%) |
| Earnings Date | Jul 28, 2026 |
About WPC
W. P. Carey Inc. ranks among the largest net lease REITs with a well-diversified portfolio of high-quality, operationally critical commercial real estate. It includes 1,703 net lease properties covering approximately 185 million square feet as of March 31, 2026. With offices in New York, London, Amsterdam and Dallas, the company remains focused on investing primarily in single-tenant, industrial, warehouse and retail properties located in the U.S. and Europe, under long-term net leases with built-in rent escalations. W. P. Carey Inc. was incorp... [Read more]
Financial Performance
In 2025, W. P. Carey's revenue was $1.71 billion, an increase of 8.20% compared to the previous year's $1.58 billion. Earnings were $466.36 million, an increase of 1.20%.
Financial StatementsAnalyst Summary
According to 13 analysts, the average rating for WPC stock is "Hold." The 12-month stock price target is $78.0, which is an increase of 2.70% from the latest price.
News
W. P. Carey Transcript: Nareit REITweek: 2026 Investor Conference
Guidance was raised on the back of strong investment activity, especially in industrial and European assets, and improved rent loss outlook. The portfolio remains resilient, with reduced exposure to riskier tenants and a focus on inflation-linked leases. Funding is secured for future investments, supporting continued growth.
Ono Pharma Announces Poster Presentation of New Clinical Data from Phase 2 Study of ONO-2808 (S1P5 Receptor Agonist) in Multiple System Atrophy at the 7th World Parkinson Congress (WPC)
OSAKA, Japan--(BUSINESS WIRE)--Ono Pharmaceutical Co., Ltd. (Headquarters: Osaka, Japan; President and COO: Toichi Takino; “Ono”) announced the presentation of data from the randomized, double-blind, ...
W.P. Carey price target raised to $78 from $72 at Barclays
Barclays raised the firm’s price target on W.P. Carey (WPC) to $78 from $72 and keeps an Underweight rating on the shares. The firm updated models in the net lease…
W.P. Carey price target raised to $78 from $72 at Barclays
Barclays raised the firm’s price target on W.P. Carey (WPC) to $78 from $72 and keeps an Underweight rating on the shares. The firm updated models in the net lease…
W.P. Carey price target raised to $79 from $73 at Scotiabank
Scotiabank raised the firm’s price target on W.P. Carey (WPC) to $79 from $73 and keeps a Sector Perform rating on the shares. Q1 earnings in the net lease REIT…
W. P. Carey Announces Year-to-Date Investment Volume Totaling $1.1 Billion
Adds $400 Million of Investment Volume Since Announcing First Quarter Results NEW YORK, May 12, 2026 /PRNewswire/ -- W. P. Carey Inc. (NYSE: WPC) (W.
W.P. Carey price target raised to $75 from $69 at Citi
Citi analyst Nick Joseph raised the firm’s price target on W.P. Carey (WPC) to $75 from $69 and keeps a Neutral rating on the shares.
W.P. Carey price target raised to $73 from $72 at RBC Capital
RBC Capital raised the firm’s price target on W.P. Carey (WPC) to $73 from $72 and keeps a Sector Perform rating on the shares. The company’s Q1 results were largely…
W. P. Carey Earnings Call Transcript: Q1 2026
AFFO per share rose 11.1% year-over-year, driven by strong investment activity and portfolio growth. Full-year guidance for investment volume and AFFO per share was raised, with robust liquidity and a well-diversified tenant base supporting continued momentum.
W. P. Carey Earnings release: Q1 2026
W. P. Carey released its Q1 2026 earnings on April 29, 2026, summarizing the period's financial results.
W. P. Carey Slides: Q1 2026
W. P. Carey has posted slides in relation to its Q1 2026 quarterly earnings report, which was published on April 29, 2026.
W. P. Carey Quarterly report: Q1 2026
W. P. Carey has published its Q1 2026 quarterly earnings report on April 29, 2026.
W. P. Carey Announces First Quarter 2026 Financial Results
NEW YORK, April 28, 2026 /PRNewswire/ -- W. P. Carey Inc. (NYSE: WPC) (W.
W.P. Carey price target raised to $72 from $68 at Barclays
Barclays raised the firm’s price target on W.P. Carey (WPC) to $72 from $68 and keeps an Underweight rating on the shares. The firm adjusted targets in the net lease…
W. P. Carey to Release First Quarter 2026 Financial Results on Tuesday, April 28, 2026
Conference Call Scheduled for Wednesday, April 29, 2026 at 11:00 a.m. Eastern Time NEW YORK, April 7, 2026 /PRNewswire/ -- W.
W. P. Carey Provides Business Update
Completes First Quarter Investment Volume of $580 Million Amends Credit Agreement Establishing Canadian-Dollar-Denominated Term Loan NEW YORK, March 31, 2026 /PRNewswire/ -- W. P. Carey Inc. (W.
W. P. Carey Proxy statement: Proxy filing
W. P. Carey filed a proxy statement on March 27, 2026, providing details for shareholder voting and corporate governance matters.
W. P. Carey Proxy statement: Proxy filing
W. P. Carey filed a proxy statement on March 27, 2026, providing details for shareholder voting and corporate governance matters.
W.P. Carey price target raised to $75 from $74 at Evercore ISI
Evercore ISI analyst James Kammert raised the firm’s price target on W.P. Carey (WPC) to $75 from $74 and keeps an In Line rating on the shares as part of…
W. P. Carey Releases 2025 CEO Letter
Successful Execution in 2025 Lays the Foundation for Sustainable Long ‑ term Growth NEW YORK, March 17, 2026 /PRNewswire/ -- W. P. Carey Inc. (W.
W.P. Carey upgraded to Outperform from Market Perform at Raymond James
Raymond James upgraded W.P. Carey (WPC) to Outperform from Market Perform with a $76 price target Raymond James adjusted ratings in the net lease real estate investment trust group given…
W.P. Carey upgraded to Outperform from Market Perform at Raymond James
Raymond James upgraded W.P. Carey (WPC) to Outperform from Market Perform with a $76 price target
W.P. Carey price target raised to $68 from $65 at Barclays
Barclays raised the firm’s price target on W.P. Carey (WPC) to $68 from $65 and keeps an Underweight rating on the shares. The firm updated models in the net lease…
W. P. Carey Increases Quarterly Dividend to $0.930 per Share
NEW YORK, March 12, 2026 /PRNewswire/ -- W. P. Carey Inc. (W.
W.P. Carey price target raised to $75 from $68 at UBS
UBS raised the firm’s price target on W.P. Carey (WPC) to $75 from $68 and keeps a Neutral rating on the shares.